| 摘要 |
The present invention relates to an anti-allergic composition including Bacillus amyloliquefaciens 26N strains (Accession No. KCCM 11287P) as an active ingredient. According to the present invention, Bacillus amyloliquefaciens 26N strains can activate antiallergic activities, activate regulator T cells, and increase the anti-inflammatory cytokine called IL10, thereby effectively controlling allergies. |
